Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis
Clinical trial NCT04709575 · COMPLETED
Trial details
- NCT number
- NCT04709575
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-14
- Primary completion
- 2021-08-24
- Enrollment
- 353
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.